美国生物技术公司Moderna（MRNA）周五盘中股价大跌8.55%，主要受到一则关于新冠疫苗安全性的负面报道影响。
据《华盛顿邮报》援引四名知情人士的话报道，特朗普政府的卫生官员正计划将冠状病毒疫苗与25名儿童的死亡联系起来。这些官员正在考虑限制某些美国人接种疫苗。报道补充说，这些发现似乎是基于提交给联邦疫苗不良事件报告系统（VAERS）的信息，其中包含未经核实的关于疫苗副作用或不良经历的报告。
作为主要的COVID-19疫苗生产商之一，Moderna的股价受到了明显冲击。同时，其他疫苗制造商如辉瑞（PFE）和Novavax的股价也出现下跌，跌幅接近3%。值得注意的是，美国卫生与公众服务部尚未对这一报道作出回应。这一消息引发了市场对疫苗安全性和未来需求的担忧，进而导致相关股票出现大幅下跌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.